Phentermine Hydrochloride NDC 72189-203

NDC codes

FDA NDC Directory

Product NDC (as listed)72189-203Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72189-0203Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72189-203-30	72189020330	30 TABLET in 1 BOTTLE (72189-203-30)Marketed from Jun 3, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phentermine Hydrochloride
Generic name (nonproprietary): phentermine hydrochloride
Active ingredients: Phentermine hydrochloride — 37.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: DIRECT RX
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203068
Marketing start: Jun 3, 2021
Listing expires: Dec 31, 2026
DEA schedule: CIV
Other FDA classes: Appetite Suppression (Physiologic effect)Increased Sympathetic Activity (Physiologic effect)
Identifiers: Product ID 72189-203_2be977e6-4cfe-9a64-e063-6294a90a9fc9SPL ID 2be977e6-4cfe-9a64-e063-6294a90a9fc9SPL set ID c3dda0a4-b428-f3e7-e053-2995a90ad106RxCUI 803353UNII 0K2I505OTV
Pharmacologic class: Sympathomimetic Amine Anorectic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472189020330 followed by a unit qualifier and the quantity

Package 72189-0203-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 17, 2025.

Indications (excerpt from the label)

Phentermine hydrochloride tablets USP are indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index greater than or equal to 30 kg/m2, or greater than or equal to 27 kg/m2 in the presence of other risk factors (e.g., controlled hypertension, diabetes, hyperlipidemia). Below is a chart of body mass index (BMI) based on various heights and weights. BMI is calculated by taking the patient's weight, in kilograms (kg), divided by the patient's height, in meters (m), squared. Metric conversions are as follows: pounds ÷ 2.2 = k…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203068

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203068
Product	Strength	Form · route	Labeler	Product NDC
Phentermine Hydrochloride	Phentermine hydrochloride 37.5 mg/1	TabletOral	Aurolife Pharma LLC	13107-061
Phentermine Hydrochloride	Phentermine hydrochloride 37.5 mg/1	TabletOral	Proficient Rx LP	63187-800